ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC13089-10mM (in 1mL DMSO) |
|
593960-11-3 |
PIK-93
|
0 | C14H16ClN3O4S2 | |
GC13089-50mg |
|
593960-11-3 |
PIK-93
|
0 | C14H16ClN3O4S2 | |
GC13089-10mg |
|
593960-11-3 |
PIK-93
|
0 | C14H16ClN3O4S2 | |
GC13089-5mg |
|
593960-11-3 |
PIK-93
|
0 | C14H16ClN3O4S2 | |
GC13088-10mg |
|
1404562-17-9 |
BRD6688
|
0 | C16H18N4O | |
GC13088-5mg |
|
1404562-17-9 |
BRD6688
|
0 | C16H18N4O | |
GC13088-1mg |
|
1404562-17-9 |
BRD6688
|
0 | C16H18N4O | |
GC13087-100mg |
|
88107-10-2 |
LY171883
|
0 | C16H22N4O3 | |
GC13087-50mg |
|
88107-10-2 |
LY171883
|
0 | C16H22N4O3 | |
GC13087-10mg |
|
88107-10-2 |
LY171883
|
0 | C16H22N4O3 | |
GC13087-5mg |
|
88107-10-2 |
LY171883
|
0 | C16H22N4O3 | |
GC13086-50mg |
|
1394854-52-4 |
GSK J2
|
0 | C22H23N5O2 | |
GC13086-10mg |
|
1394854-52-4 |
GSK J2
|
0 | C22H23N5O2 | |
GC13085-250mg |
|
63590-64-7 |
Terazosin
|
0 | C19H25N5O4 | |
GC13085-50mg |
|
63590-64-7 |
Terazosin
|
0 | C19H25N5O4 | |
GC13084-500mg |
|
759-05-7 |
Ketoisovaleric acid
|
0 | C5H8O3 | |
GC13084-100mg |
|
759-05-7 |
Ketoisovaleric acid
|
0 | C5H8O3 | |
GC13083-100mg |
|
147817-50-3 |
Siramesine
|
0 | C30H31FN2O | |
GC13083-50mg |
|
147817-50-3 |
Siramesine
|
0 | C30H31FN2O | |
GC13083-25mg |
|
147817-50-3 |
Siramesine
|
0 | C30H31FN2O | |